Search results
Results From The WOW.Com Content Network
Ductal carcinoma in situ, also called DCIS, also may be treated with radiation therapy and medicines. DCIS treatment has a high likelihood of success. In most instances, the cancer is removed and has a low chance of coming back after treatment.
About 1 in 5 new breast cancers will be ductal carcinoma in situ (DCIS). Nearly all women with this early stage of breast cancer can be cured. DCIS is also called intraductal carcinoma or stage 0 breast cancer. DCIS is a non-invasive or pre-invasive breast cancer.
It’s important to understand that radiation and hormone treatments do not change survival—the 10-year survival rate for women diagnosed with DCIS is 98% regardless of whether they receive either treatment. These treatments instead reduce the risk of breast cancer down the road.
DCIS can be found alone or with invasive breast cancer. If it’s diagnosed with invasive breast cancer, treatment and the chances of survival are based on the invasive breast cancer, not the DCIS. Learn about treatment for early breast cancer.
DCIS today accounts for around 20% of breast cancer diagnoses. Because DCIS is found at cancer’s earliest stage, it responds very well to treatment. The outlook for patients with DCIS is excellent, and the disease has a 10-year survival rate of more than 98%.
The ductal carcinoma in situ survival rates are generally positive. More than 98 percent of patients who are diagnosed with stage 0 breast cancer survive at least five years after their original diagnosis. While a few patients will experience recurrences, the survival rates are still encouraging.
Diagnosis. Treatment. Outlook. Takeaway. DCIS has a very good outlook. 50 to 80 percent of cases won’t become invasive. You have a handful of different treatment options, including...
Ductal carcinoma in situ (DCIS) now represents 20–25% of all ‘breast cancers’ consequent upon detection by population-based breast cancer screening programmes. Currently, all DCIS...
Ductal carcinoma in situ (DCIS) accounts for 15–25% of all breast cancer diagnoses. Its prognosis is excellent overall, the main risk being the occurrence of local breast events, as most cases of DCIS do not progress to invasive cancer.
What Is Invasive Ductal Carcinoma? Invasive (or infiltrating) ductal carcinoma (IDC) accounts for about 80% of all invasive breast cancers. It begins in the cells of a milk duct, then it grows...